Researchers might have discovered a unexpected ally in the battle against Alzheimer's disease—spearheading cholesterol-reducing medications. Recent studies indicate that medications such as statins, which have been prescribed over many years to forestall heart attacks and strokes, might also confer significant protection against mental decline.
A paper in the Journal of Neurology, Neurosurgery and Psychiatry has found that those with low levels of "bad" cholesterol (LDL-C) not only have fewer cardiac risks but also have a significantly lower risk of dementia, including Alzheimer's disease. The presence of statins in those with low LDL-C levels further increased this benefit.
These results, coupled with corroborating evidence from U.S.-based scientists, pave the way to rethink how we keep cardiovascular health in line—now with consideration of the brain.
Statins are among the most prescribed medications worldwide, with 7–8 million individuals in the UK alone taking them to avoid cardiovascular events. The drugs act by lowering low-density lipoprotein (LDL) cholesterol, the so-called "bad cholesterol," which can block arteries and lead to heart attacks and strokes.
A more in-depth look at population-level health information from South Korea, on over 570,000 people, added a fascinating new twist: the lowest LDL-C group—below 1.8 mmol/L—were 26% less likely to have dementia and 28% less likely to have Alzheimer's than the group with LDL-C of more than 3.4 mmol/L.
Additionally, statin users with low levels of LDL-C had a further 13% lower risk of dementia and 12% lower risk of Alzheimer's than non-users.
"These results highlight the significance of LDL-C management not only in preventing heart disease but as a key component of an anticipatory approach to neurodegenerative disease prevention," researchers stated in their study. "Targeted statin prescriptions that aim at optimal levels of LDL-C could maximize cardiovascular as well as cognitive benefit."
Yet another study, this one from the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases at UT Health San Antonio, supports the notion that the relationship between brain and cholesterol is real—but not necessarily simple.
Dr. Sokratis Charisis, a neurologist and senior researcher, examined data from the landmark Framingham Heart Study and reaffirmed that high levels of LDL are causally linked with cardiovascular disease and dementia.
Though, the information pulled a surprise in regard to HDL—often called "good cholesterol." Long hailed for its cardio-protective qualities, low levels of HDL were found to be associated with a decreased risk of Alzheimer's disease, indicating a more nuanced biological interaction between cholesterol subtypes and cognitive impairment.
"It speaks to the fact that this relationship may not be as straightforward as we believe," said Dr. Charisis. "There may be completely different mechanisms linking blood lipids to brain health as opposed to cardiovascular health."
Charisis also pointed out a third lipid marker—ApoB48, a lipoprotein that carries dietary fats in the blood. Though not usually tested as part of regular cholesterol checks, higher levels of ApoB48 were associated with a reduced risk of Alzheimer's, suggesting unforeseen levels of biological interplay between the diet, lipid metabolism, and brain deterioration.
"This finding is especially noteworthy," said Charisis, "because it potentially could be used to help identify a new biomarker that can ultimately inform predictive diagnostics and personalized treatment strategies."
The significance of this developing research is immense. As of 2019, an estimated 57.4 million individuals globally were affected by dementia, a figure that is predicted to increase more than twice over—that is, 152 million by the year 2050, according to international health organizations.
As Alzheimer's disease is responsible for most cases of dementia and there is no cure yet, prevention and early treatment are more essential than ever. Changes in lifestyle, reduction of cardiovascular risk, and now control of lipids could be the cornerstones of a multi-faceted approach to neurodegeneration.
While statins have traditionally been seen from the perspective of heart health, this new evidence indicates they might also be repurposed or more targeted in their prescribing for brain health, particularly among aging adults.
Yet the results also highlight the importance of individualization. What is good for one brain may not be equally useful for another, especially when age and cholesterol levels are considered. "Perhaps it will be crucial to have dynamic cholesterol targets depending on the patient's age, health status, and genetic profile," Charisis said.
This opens up the possibility of more individualized treatment regimens—not only prescribing statins by cardiac risk, but also including cognitive health evaluations in the decision-making process.
For the time being, specialists continue to recommend regular monitoring of cholesterol levels and early treatment of cardiovascular risk factors. Although you shouldn't start statin therapy just to minimize dementia risk without a doctor's advice, having a healthy LDL-C value is a definite boon to both heart and brain.
Individuals worried about cognitive impairment—particularly those with a family history of Alzheimer's—are advised to:
Adopt habits of lifestyle that foster both cardiovascular and cognitive health: exercise, a Mediterranean diet, managing stress, and sleep
From childhood, many girls are taught to be agreeable, responsible and perfect in everything they do. They are praised for being obedient, hardworking and emotionally controlled. Over time, this expectation can shape behavior in ways that may quietly harm mental and physical health.
This pattern is often referred to as “Good Girl Syndrome”. While it is not a formal medical diagnosis, doctors say the effects of constantly trying to live up to expectations can be very real. The pressure to appear composed and capable all the time can lead to emotional suppression, chronic stress and eventually hormonal disturbances.
To understand how this pressure affects the body, NDTV Health spoke with Dr. Y. D. Meherprasad, Senior Consultant in Endocrinology and Preventive Healthcare at MGM Malar Hospital, Chennai, who says he has observed this pattern among many young women in his clinical practice.
Good Girl Syndrome describes a behavioral pattern where individuals, often women, feel compelled to meet expectations without showing weakness or stress. This can translate into people pleasing behaviour, fear of conflict and difficulty setting boundaries.
Dr. Meherprasad explains that constantly trying to maintain this image can create a persistent stress response in the body.
“Hormonal imbalances are being noticed in young Indian women associated with the Good Girl Syndrome, where women are always trying to meet expectations and are continuously successful, all without showing any signs of stress,” he told NDTV Health.
According to him, the problem arises when emotions are suppressed for long periods. “When women suppress emotions for long periods, the body remains in a state of constant stress response,” he said.
Emerging research in the field of psychoneuroendocrinology suggests that emotional stress can directly influence hormonal regulation in the body.
At the centre of this process is cortisol, the body’s main stress hormone. Normally, cortisol rises briefly during stressful situations and then returns to normal levels once the threat passes.
However, when stress becomes constant, cortisol levels can remain elevated for long periods.
Studies have shown that chronic high cortisol can disrupt reproductive hormones. One effect described in research is sometimes called “progesterone steal,” where the body prioritizes producing stress hormones instead of reproductive hormones.
Low progesterone levels can contribute to irregular menstrual cycles, acne and other hormonal symptoms that many young women experience.
Dr. Meherprasad says chronic stress may also contribute to metabolic changes. In some cases, it can mimic or worsen conditions such as Polycystic Ovary Syndrome (PCOS).
When cortisol levels remain high, the body releases more glucose into the bloodstream to provide energy for a perceived threat. If that energy is not used through physical activity, insulin levels rise to regulate blood sugar.
Over time, this can lead to insulin resistance, which is a key factor associated with PCOS. Women may experience abdominal weight gain, irregular ovulation and difficulty managing their weight.
The effects of prolonged stress do not appear overnight. They often show up gradually through subtle changes in the body.
Dr. Meherprasad says menstrual irregularities are one of the early warning signs. Some women may experience delayed cycles or even a temporary halt in ovulation.
Sleep disturbances are also common. Many women report difficulty falling asleep because their minds remain constantly active, leading to fatigue the next day.
Other symptoms may include mood swings, persistent anxiety, brain fog and difficulty losing weight despite maintaining a careful diet.
Dr. Meherprasad says addressing these hormonal issues requires both medical evaluation and lifestyle changes.
Regular hormone screenings can help detect issues related to thyroid function, insulin levels and reproductive hormones such as LH and FSH. Early treatment is important if conditions such as PCOS or thyroid dysfunction are present.
Equally important is addressing the emotional component of chronic stress.
“Hormonal imbalance is not only physical but also closely linked to emotional health,” said the doctor.
He recommends prioritizing adequate sleep, regular physical activity and practices such as yoga that help calm the body’s stress response. Creating space for emotional expression through journaling or therapy can also help reduce long term stress.
In a culture that often rewards perfection, doctors say it may be time to rethink the idea of the “perfect girl”. Sometimes, protecting one’s health begins with allowing space for imperfection.
Cancer deaths in the United Kingdom have dropped to their lowest recorded levels, according to new data from the charity Cancer Research UK. The figures show that cancer death rates have fallen by 11 per cent in the past decade, reflecting progress in early detection, screening, treatment and prevention.
Researchers estimate that around 247 people in every 100,000 in the UK now die from cancer each year. This is a significant decline from the peak recorded in 1989, when about 355 people per 100,000 died annually from the disease. Overall, that represents a 29 per cent reduction over the past few decades.
Experts say this steady improvement is the result of sustained scientific progress, improved healthcare systems and public health measures that target risk factors such as smoking.
The new data highlights falling death rates across several major cancers. Ovarian cancer deaths have dropped by 19 per cent over the past ten years, up to 2024. Lung cancer deaths have fallen by 22 per cent during the same period, reflecting the long-term impact of reduced smoking rates and better treatment options.
Deaths from stomach cancer have seen one of the most dramatic improvements, dropping by 34 per cent in the past decade. Bowel cancer deaths have decreased by six per cent, while breast cancer deaths have fallen by 14 per cent.
Other cancers have also seen notable declines. Cervical and prostate cancer deaths have both dropped by 11 per cent. Deaths from leukemia are down by nine per cent, while esophageal cancer deaths have fallen by 12 per cent.
Experts say improved diagnosis, new therapies and better awareness are playing a key role in these trends.
One of the biggest public health successes has been the decline in cervical cancer deaths. Since the 1970s, deaths from cervical cancer have fallen by around 75 per cent in the UK. Health experts attribute much of this progress to the national cervical screening programme run by the NHS.
Screening helps detect abnormal cells early, allowing treatment before cancer develops or spreads.
Another major contributor is the human papillomavirus vaccine, commonly known as the HPV vaccine. The vaccine protects against the virus responsible for most cervical cancer cases. It is routinely offered to schoolchildren in the UK, and since its introduction in 2008, at least 6.5 million young people have received it.
Public health experts believe the vaccine will continue to reduce cervical cancer rates in the coming decades.
Despite the overall progress, the data also shows worrying increases in deaths from certain cancers. Gallbladder cancer deaths have risen by 29 per cent, while deaths from eye cancer have increased by 26 per cent.
Liver cancer deaths are up by 14 per cent, and kidney cancer deaths have risen by five per cent. Meanwhile, death rates for thyroid cancer, pancreatic cancer and melanoma have remained largely unchanged.
Another important trend is that the total number of people dying from cancer continues to rise. This is largely due to population growth and an ageing population, as cancer risk increases with age.
Experts say the long-term decline in cancer deaths reflects decades of medical research and innovation. However, they stress that continued investment is necessary to sustain progress.
Cancer Research UK researcher Dr Sam Godfrey said the figures show the impact of scientific breakthroughs over many years. He has called on the government to support more clinical trials and ensure that NHS staff have enough time and resources to take part in life saving research.
Public health policies such as smoking bans, along with screening programmes and vaccines, are also credited with helping drive down cancer deaths across the country.
Credit: Canva
Are you in the habit of catching up on social media or news updates while sitting on the pot? A new study shows you may be "unintentionally" spending extra time and increasing your risk of developing painful hemorrhoids by 46 percent.
The study, published in the open-access journal PLOS One, explained that getting distracted by news or social media can increase pressure on sensitive anal tissues, which leads to hemorrhoids.
Hemorrhoids, also called piles, are swollen and inflamed veins around your anus or in your lower rectum.
"Using a smartphone while on the toilet was linked to a 46 percent increased chance of having hemorrhoids. We're still uncovering the many ways smartphones and our modern way of life impact our health,” Trisha Pasricha, from the Beth Israel Deaconess Medical Center in the US.
“It's possible that how and where we use them -- such as while in the bathroom -- can have unintended consequences," she added.
For the study, the researchers examined data from colonoscopies of 125 adults in America, and conducted an online survey to understand their lifestyle habits and behavior while using the toilet.
Two-thirds of the participants reported using their smartphones while on
the toilet. Compared with those who did not, endoscopists found that they had a 46 percent higher risk of hemorrhoids.
More than a third of bathroom smartphone users reported spending more than five minutes there during a single visit -- reading news (54.3 percent), or browsing social media (44.4 percent).
In comparison, just 7.1 percent of non-users reported staying that long.
"Smartphone use may unintentionally extend the time people spend sitting on the toilet. Sitting for longer periods could increase pressure on tissues in the anal region, which may contribute to the development of hemorrhoids,” the researchers said.
Pasricha suggested individuals leave smartphones outside the bathroom to understand the actual time it takes for a bowel movement.
"If it's taking longer, ask yourself why. Was it because having a bowel movement was really so difficult, or was it because my focus was elsewhere?" she said, calling for more studies.
Studies estimate that hemorrhoidal disease affects 40% of people all over the world, and it is one of the most common diseases in the anorectal region.
The two types of hemorrhoids are:
© 2024 Bennett, Coleman & Company Limited